Hosted on MSN1d
JMP Securities Initiates Coverage of Context Therapeutics (CNTX) with Market Outperform RecommendationFintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...
DBV Technologies (DBVT) announced twenty-four month results from its Open-Label Extension Study of EPITOPE. The data provide support that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback